Browse > Article
http://dx.doi.org/10.4062/biomolther.2020.001

Repositioned Drugs for Inflammatory Diseases such as Sepsis, Asthma, and Atopic Dermatitis  

Prakash, Annamneedi Venkata (Convergence Research Center, Department of Pharmacy and Institute of Chronic Disease, Sahmyook University)
Park, Jun Woo (Convergence Research Center, Department of Pharmacy and Institute of Chronic Disease, Sahmyook University)
Seong, Ju-Won (Convergence Research Center, Department of Pharmacy and Institute of Chronic Disease, Sahmyook University)
Kang, Tae Jin (Convergence Research Center, Department of Pharmacy and Institute of Chronic Disease, Sahmyook University)
Publication Information
Biomolecules & Therapeutics / v.28, no.3, 2020 , pp. 222-229 More about this Journal
Abstract
The process of drug discovery and drug development consumes billions of dollars to bring a new drug to the market. Drug development is time consuming and sometimes, the failure rates are high. Thus, the pharmaceutical industry is looking for a better option for new drug discovery. Drug repositioning is a good alternative technology that has demonstrated many advantages over de novo drug development, the most important one being shorter drug development timelines. In the last two decades, drug repositioning has made tremendous impact on drug development technologies. In this review, we focus on the recent advances in drug repositioning technologies and discuss the repositioned drugs used for inflammatory diseases such as sepsis, asthma, and atopic dermatitis.
Keywords
Drug repositioning; Inflammatory disease; Sepsis; Asthma; Atopic dermatitis;
Citations & Related Records
Times Cited By KSCI : 1  (Citation Analysis)
연도 인용수 순위
1 Zarjou, A. and Agarwal, A. (2011) Sepsis and acute kidney injury. J. Am. Soc. Nephrol. 22, 999-1006.   DOI
2 Holmes, A. B., Hawson, A., Liu, F., Friedman, C., Khiabanian, H. and Rabadan, R. (2011) Discovering disease associations by integrating electronic clinical data and medical literature. PLoS ONE 6, e21132.   DOI
3 Huang, C. C., Chan, W. L., Chen, Y. C., Chen, T. J., Chou, K. T., Lin, S. J., Chen, J. W. and Leu, H. B. (2011) Statin use in patients with asthma: a nationwide population-based study. Eur. J. Clin. Invest. 41, 507-512.   DOI
4 Mushaben, E. M., Kramer, E. L., Brandt, E. B., Khurana Hershey, G. K. and Le Cras, T. D. (2011) Rapamycin attenuates airway hyperreactivity, goblet cells, and IgE in experimental allergic asthma. J. Immunol. 187, 5756-5763.   DOI
5 O'Connor, K. A. and Roth, B. L. (2005) Finding new tricks for old drugs: an efficient route for public-sector drug discovery. Nat. Rev. Drug Discov. 4, 1005-1014.   DOI
6 Oduah, E. I., Linhardt, R. J. and Sharfstein, S. T. (2016) Heparin: past, present, and future. Pharmaceuticals (Basel) 9, e38.
7 Oprea, T. I., Nielsen, S. K., Ursu, O., Yang, J. J., Taboureau, O., Mathias, S. L., Kouskoumvekaki, L., Sklar, L. A. and Bologa, C. G. (2011) Associating drugs, targets and clinical outcomes into an integrated network affords a new platform for computer-aided drug repurposing. Mol. Inform. 30, 100-111.   DOI
8 Ostroukhova, M., Kouides, R. W. and Friedman, E. (2009) The effect of statin therapy on allergic patients with asthma. Ann. Allergy Asthma Immunol. 103, 463-468.   DOI
9 Papi, A., Brightling, C., Pedersen, S. E. and Reddel, H. K. (2018) Asthma. Lancet 391, 783-800.   DOI
10 Petersen, L. J., Mosbech, H. and Skov, P. S. (1996) Allergen-induced histamine release in intact human skin in vivo assessed by skin microdialysis technique: characterization of factors influencing histamine releasability. J. Allergy Clin. Immunol. 97, 672-679.   DOI
11 Ashburn, T. T. and Thor, K. B. (2004) Drug repositioning: identifying and developing new uses for existing drugs. Nat. Rev. Drug Discov. 3, 673-683.   DOI
12 Phatak, S. S. and Zhang, S. (2013) A novel multi-modal drug repurposing approach for identification of potent ACK1 inhibitors. Pac. Symp. Biocomput. 2013, 29-40.
13 Phelps, K. (2011) Repositioning drugs to enhance a product's lifecycle. Drug Discov. Today Ther. Strateg. 8, 97-101.   DOI
14 Reddy, A. R. and Kaul, A. (1979) Effect of methyl thiouracil on radioiodine thyroidal retention in rats. Radiat. Environ. Biophys. 16, 347-354.   DOI
15 Aderibigbe, A. O., Emudianughe, T. S. and Lowal, B. A. (1999) Antihyperglycaemic effect of Mangifera indica in rat. Phytother. Res. 13, 504-507.   DOI
16 Alaez-Verson, C. R., Lantero, E. and Fernandez-Busquets, X. (2017) Heparin: new life for an old drug. Nanomedicine (Lond.) 12, 1727-1744.   DOI
17 Barnes, P. J. (2017) Cellular and molecular mechanisms of asthma and COPD. Clin. Sci. (Lond.) 131, 1541-1558.   DOI
18 Barnes, P. J. (2015) Therapeutic approaches to asthma-chronic obstructive pulmonary disease overlap syndromes. J. Allergy Clin. Immunol. 136, 531-545.   DOI
19 Jang, D., Lee, S., Lee, J., Kim, K. and Lee, D. (2016) Inferring new drug indications using the complementarity between clinical disease signatures and drug effects. J. Biomed. Inform. 59, 248-257.   DOI
20 Iorio, F., Bosotti, R., Scacheri, E., Belcastro, V., Mithbaokar, P., Ferriero, R., Murino, L., Tagliaferri, R., Brunetti-Pierri, N., Isacchi, A. and di Bernardo, D. (2010) Discovery of drug mode of action and drug repositioning from transcriptional responses. Proc. Natl. Acad. Sci. U.S.A. 107, 14621-14626.   DOI
21 Jensen, P. B., Jensen, L. J. and Brunak, S. (2012) Mining electronic health records: towards better research applications and clinical care. Nat. Rev. Genet. 13, 395-405.   DOI
22 Jung, K., LePendu, P., Chen, W. S., Iyer, S. V., Readhead, B., Dudley, J. T. and Shah, N. H. (2014) Automated detection of off-label drug use. PLoS ONE 9, e89324.   DOI
23 Jung, K., LePendu, P. and Shah N. H. (2013) Automated detection of systematic off-label drug use in free text of electronic medical records. AMIA Jt. Summits Transl. Sci. Proc. 2013, 94-98.
24 Kalesnikoff, J. and Galli, S. J. (2008) New developments in mast cell biology. Nat. Immunol. 9, 1215-1223.   DOI
25 Roque, F. S., Jensen, P. B., Schmock, H., Dalgaard, M., Andreatta, M., Hansen, T., Soeby, K., Bredkjær, S., Juul, A., Werge, T., Jensen, L. J. and Brunak, S. (2011) Using electronic patient records to discover disease correlations and stratify patient cohorts. PLoS Comput. Biol. 7, e1002141.   DOI
26 Keiser, M. J., Setola, V., Irwin, J. J., Laggner, C., Abbas, A. I., Hufeisen, S. J., Jensen, N. H., Kuijer, M. B., Matos, R. C., Tran, T. B., Whaley, R., Glennon, R. A., Hert, J., Thomas, K. L., Edwards, D. D., Shoichet, B. K. and Roth, B. L. (2009) Predicting new molecular targets for known drugs. Nature 462, 175-181.   DOI
27 Kim, D. Y., Ryu, S. Y., Lim, J. E., Lee, Y. S. and Ro, J. Y. (2007) Antiinflammatory mechanism of simvastatin in mouse allergic asthma model. Eur. J. Pharmacol. 557, 76-86.   DOI
28 Kim, S. H., Lee, K. M., Lee, G. S., Seong, J. W. and Kang, T. J. (2017) Rifampicin alleviates atopic dermatitis-like response in vivo and in vitro. Biomol. Ther. (Seoul) 25, 634-640.   DOI
29 Rihel, J., Prober, D. A., Arvanites, A., Lam, K., Zimmerman, S., Jang, S., Haggarty, S. J., Kokel, D., Rubin, L. L., Peterson, R. T. and Schier, A. F. (2010) Zebrafish behavioral profiling links drugs to biological targets and rest/wake regulation. Science 327, 348-351.   DOI
30 Robinson, J. G. (2007) Simvastatin: present and future perspectives. Expert Opin. Pharmacother. 8, 2159-2127.   DOI
31 Russell, J. A. (2006) Management of sepsis. N. Engl. J. Med. 355, 1699-1713.   DOI
32 Ryu, J. C., Park, S. M., Hwangbo, M., Byun, S. H., Ku, S. K., Kim, Y. W., Kim, S. C., Jee, S. Y. and Cho, I. J. (2013) Methanol extract of Artemisia apiacea Hance attenuates the expression of inflammatory mediators via NF-kappaB inactivation. Evid. Based Complement. Altern. Med. 2013, 494681.   DOI
33 Samson, K. T., Minoguchi, K., Tanaka, A., Oda, N., Yokoe, T., Yamamoto, Y., Yamamoto, M., Ohta, S. and Adachi, M. (2006) Inhibitory effects of fluvastatin on cytokine and chemokine production by peripheral blood mononuclear cells in patients with allergic asthma. Clin. Exp. Allergy 36, 475-482.   DOI
34 Campillos, M., Kuhn, M., Gavin, A. C., Jensen, L. J. and Bork, P. (2008) Drug target identification using side-effect similarity. Science 321, 263-266.   DOI
35 Sanseau, P. and Koehler, J. (2011) Editorial: computational methods for drug repurposing. Brief. Bioinformatics 12, 301-302.   DOI
36 Sardana, D., Zhu, C., Zhang, M., Gudivada, R. C., Yang, L. and Jegga, A. G. (2011) Drug repositioning for orphan diseases. Brief. Bioinformatics 12, 346-356.   DOI
37 Bateman, E. D., Hurd, S. S., Barnes, P. J., Bousquet, J., Drazen, J. M., FitzGerald, J. M., Gibson, P., Ohta, K., O'Byrne, P., Pedersen, S. E., Pizzichini, E., Sullivan, S. D., Wenzel, S. E. and Zar, H. J. (2008) Global strategy for asthma management and prevention: GINA executive summary. Eur. Respir. J. 31, 143-178.   DOI
38 Bellahsene, A. and Forsgren, A. (1980) Effect of rifampin on the immune response in mice. Infect. Immun. 27, 15-20.   DOI
39 Bergmann, R. L., Edenharter, G., Bergmann, K. E., Forster, J., Bauer, C. P., Wahn, V., Zepp, F. and Wahn, U. (1998) Atopic dermatitis in early infancy predicts allergic airway disease at 5 years. Clin. Exp. Allergy 28, 965-970.   DOI
40 Bernard, G. R., Vincent, J. L, Laterre, P. F., LaRosa S. P., Dhainau, J. F., Lopez-Rodriguez, A., Steingrub, J. S., Garber, G. E., Helterbrand, J. D., Ely, E. W. and Fisher, C. J., Jr.; Recombinant human protein C Worldwide Evaluation in Severe Sepsis (PROWESS) study group (2001) Efficacy and safety of recombinant human activated protein C for severe sepsis. N. Engl. J. Med. 344, 699-709.   DOI
41 Chang, M. W., Ayeni, C., Breuer, S. and Torbett, B. E. (2010) Virtual screening for HIV protease inhibitors: a comparison of AutoDock 4 and Vina. PLoS ONE 5, e11955.   DOI
42 Chang T. W. and Shiung, Y. Y. (2006) Anti-IgE as a mast cell-stabilizing therapeutic agent. J. Allergy Clin. Immunol. 117, 1203-1212.   DOI
43 Chen, Y. Z. and Zhi, D. G. (2011) Ligand-protein inverse docking and its potential use in the computer search of protein targets of a small molecule. Proteins 43, 217-226.   DOI
44 Chong, C. R. and Sullivan, D. J. (2007) New uses for old drugs. Nature 448, 645-646.   DOI
45 Li, J. and Lu, Z. (2013) Pathway-based drug repositioning using causal inference. BMC Bioinformatics 14 Suppl 16, S3.
46 Kinnings, S. L., Liu, N., Buchmeier, N., Tonge, P. J., Xie, L. and Bourne, P. E. (2009) Drug discovery using chemical systems biology: repositioning the safe medicine Comtan to treat multi-drug and extensively drug resistant tuberculosis. PLoS Comput. Biol. 5, e1000423.   DOI
47 Kotelnikova, E., Yuryev, A., Mazo, I. and Daraselia, N. (2010) Computational approaches for drug repositioning and combination therapy design. J. Bioinform. Comput. Biol. 8, 593-606.   DOI
48 Kwak, S., Ku, S. K., Kang, H., Baek, M. C. and Bae, J. S. (2015) Methylthiouracil, a new treatment option for sepsis. Vascul. Pharmacol. 88, 1-10.   DOI
49 Lamb, J., Crawford, E. D., Peck, D., Modell, J. W., Blat, I. C., Wrobel, M. J., Lerner, J., Brunet, J. P., Subramanian, A., Ross, K. N., Reich, M., Hieronymus, H., Wei, G., Armstrong, S. A., Haggarty, S. J., Clemons, P. A., Wei, R., Carr, S. A., Lander, E. S. and Golub, T. R. (2006) The Connectivity Map: using gene-expression signatures to connect small molecules, genes, and disease. Science 313, 1929-1935.   DOI
50 Leung, D. Y., Boguniewicz, M., Howell, M. D., Nomura, I. and Hamid, Q. A. (2004) New insights into atopic dermatitis. J. Clin. Invest. 113, 651-657.   DOI
51 Li, Y. Y., An, J. and Jones, S. J. (2006) A large-scale computational approach to drug repositioning. Genome Inform. 17, 239-247.
52 Liu, J., Suh, D., Yang, E., Lee, S., Park, H. and Shin, Y. (2014) Attenuation of airway inflammation by simvastatin and the implications for asthma treatment: is the jury still out? Exp. Mol. Med. 46, e113.   DOI
53 Liu, X., Zhu, F., Ma, X. H., Shi, Z., Yang, S. Y., Wei, Y. Q. and Chen, Y. Z. (2013) Predicting targeted polypharmacology for drug repositioning and multi- target drug discovery. Curr. Med. Chem. 20, 1646-1661.   DOI
54 Sivachenko, A., Kalinin, A. and Yuryev, A. (2006) Pathway analysis for design of promiscuous drugs and selective drug mixtures. Curr. Drug Discov. Technol. 3, 269-277.   DOI
55 Schmidt, H., Hennen, R., Keller, A., Russ, M., Muller-Werdan, U., Werdan, K. and Buerke, M. (2006) Association of statin therapy and increased survival in patients with multiple organ dysfunction syndrome. Intensive Care Med. 32, 1248-1251.   DOI
56 Sekhon, B. S. (2013) Repositioning drugs and biologics: retargeting old/existing drugs for potential new therapeutic applications. J. Pharm. Educ. Res. 4, 1-15.
57 Sirota, M., Dudley, J. T., Kim, J., Chiang, A. P., Morgan, A. A., Sweet-Cordero, A., Sage, J. and Butte, A. J. (2011) Discovery and preclinical validation of drug indications using compendia of public gene expression data. Sci. Transl. Med. 3, 96ra77.   DOI
58 Sleigh, S. H. and Barton, C. L. (2010) Repurposing strategies for therapeutics. Pharm. Med. 24, 151-159.   DOI
59 Strittmatter, W. J. (2012) Medicine. Old drug, new hope for Alzheimer's disease. Science 35, 1447-1448.   DOI
60 Tobinick, E. L. (2009) The value of drug repositioning in the current pharmaceutical market. Drug News Perspect. 22,119-125.   DOI
61 Dudley, J. T., Sirota, M., Shenoy, M., Pai, R. K., Roedder, S., Chiang, A. P., Morgan, A. A., Sarwal, M. M., Pasricha, P. J. and Butte, A. J. (2011b) Computational repositioning of the anticonvulsant topiramate for inflammatory bowel disease. Sci. Transl. Med. 3, 96ra76.   DOI
62 Tsankov, N. and Angelova, I. (2003) Rifampin in dermatology. Clin. Dermatol. 21, 50-55.   DOI
63 Vezina, C., Kudelski, A. and Sehgal, S. N. (1975) Rapamycin (AY-22,989), a new antifungal antibiotic. I. Taxonomy of the producing streptomycete and isolation of the active principle. J. Antibiot. 28, 721-726.   DOI
64 Waldner, M., Fantus, D., Solari, M. and Thomson, A. W. (2016) New perspectives on mTOR inhibitors (rapamycin, rapalogs and TORKinibs) in transplantation. Br. J. Clin. Pharmacol. 82, 1158-1170.   DOI
65 Cramer, P. E., Cirrito, J. R., Wesson, D. W., Lee, C. Y., Karlo, J. C., Zinn, A. E., Casali, B. T., Restivo, J. L., Goebel, W. D., James, M. J., Brunden, K. R., Wilson, D. A. and Landreth, G. E. (2012) ApoE-directed therapeutics rapidly clear beta-amyloid and reverse deficits in AD mouse models. Science 335, 1503-1506.   DOI
66 Dudley, J. T., Deshpande, T. and Butte, A. J. (2011a) Exploiting drugdisease relationships for computational drug repositioning. Brief. Bioinformatics 12, 303-311.   DOI
67 Ekins, S., Williams, A. J., Krasowski, M. D., Joel, S. and Freundlich, J. S. (2011) In silico repositioning of approved drugs for rare and neglected diseases. Drug Discov. Today 16, 298-310.   DOI
68 Eule, H., Werner, E., Winsel, K. and Iwainsky, H. (1974) Intermittent chemotherapy of pulmonary tuberculosis using rifampicin and isoniazid for primary treatment: the influence of various factors on the frequency of side-effects. Tubercle 55, 81-89.   DOI
69 Ghonim, M. A., Wang, J., Ibba, S. V., Luu, H. H., Pyakurel, K., Benslimane, I., Mousa, S. and Boulares, A. H. (2018) Sulfated non-anticoagulant heparin blocks Th2-induced asthma by modulating the IL-4/signal transducer and activator of transcription 6/Janus kinase 1 pathway. J. Transl. Med. 16, 243.   DOI
70 Glock, G. E. (1946) Methyl-thiouracil and thiouracil as antithyroid drugs. Br. J. Pharmacol. Chemother. 1, 127-134.   DOI
71 Menzies, D., Nair, A., Meldrum, K. T., Fleming, D., Barnes, M. and Lipworth, B. J. (2007) Simvastatin does not exhibit therapeutic anti-inflammatory effects in asthma. J. Allergy Clin. Immunol. 119, 328-335.   DOI
72 Lokhandwala, T., West-Strum, D., Banahan, B. F., Bentley, J. P. and Yang, Y. (2012) Do statins improve outcomes in patients with asthma on inhaled corticosteroid therapy? A retrospective cohort analysis. BMJ Open 2, e001279.   DOI
73 Guha, S., Ghosal, S. and Chattopadhyay, U. (1996) Antitumor, immunomodulatory and anti-HIV effect of mangiferin, a naturally occurring glucosylxanthone. Chemotherapy 42, 443-451.   DOI
74 Lounkine, E., Keiser, M. J., Whitebread, S., Mikhailov, D., Hamon, J., Jenkins, J. L., Lavan, P., Weber, E., Doak, A. K., Cote, S., Shoichet, B. K. and Urban, L. (2012) Large-scale prediction and testing of drug activity on side-effect targets. Nature 486, 361-367.   DOI
75 Maneechotesuwan, K., Ekjiratrakul, W., Kasetsinsombat, K., Wongkajornsilp, A. and Barnes, P. J. (2010) Statins enhance the antiinflammatory effects of inhaled corticosteroids in asthmatic patients through increased induction of indoleamine 2 , 3-dioxygenase. J. Allergy Clin. Immunol. 126, 754-762.e1.   DOI
76 Matkowski, A., Kus, P., Goralska, E. and Wozniak, D. (2013) Mangiferin - a bioactive xanthonoid, not only from mango and not just antioxidant. Mini Rev. Med. Chem. 13, 439-455.   DOI
77 Medzhitov, R. (2008) Origin and physiological roles of inflammation. Nature 454, 428-435.   DOI
78 Mei, J. P., Kwoh, C. K., Yang, P., Li, X. L. and Zheng, J. (2013) Drugtarget interaction prediction by learning from local information and neighbors. Bioinformatics 29, 238-245.   DOI
79 Morrow, J. K., Tian, L. and Zhang, S. (2010) Molecular networks in drug discovery. Crit. Rev. Biomed. Eng. 38, 143-156.   DOI
80 Mousavi, S., Moradi, M., Khorshidahmad, T. and Motamedi, M. (2015) Anti-inflammatory effects of heparin and its derivatives: a systematic review. Adv. Pharmacol. Sci. 2015, 507151.   DOI
81 Yamanishi, Y., Araki, M., Gutteridge, A., Honda, W. and Kanehisa, M. (2008) Prediction of drug-target interaction networks from the integration of chemical and genomic spaces. Bioinformatics 24, i232-i240.   DOI
82 Wehrli, W., Knusel, F., Schmid, K. and Staehelin, M. (1968) Interaction of rifamycin with bacterial RNA polymerase. Proc. Natl. Acad. Sci. U.S.A. 61, 667-673.   DOI
83 Wishart, D. S., Knox, C., Guo, A. C., Cheng, D., Shrivastava, S., Tzur, D., Gautam, B. and Hassanali, M. (2008) DrugBank: a knowledgebase for drugs, drug actions and drug targets. Nucleic Acids Res. 36, D901-D906.   DOI
84 Woodside, D. G. and Vanderslice, P. (2008) Cell adhesion antagonists: therapeutic potential in asthma and chronic obstructive pulmonary disease. BioDrugs 22, 85-100.   DOI
85 Yamanishi, Y., Kotera, M., Kanehisa, M. and Goto, S. (2010) Drugtarget interaction prediction from chemical, genomic and pharmacological data in an integrated framework. Bioinformatics 26, i246-i254.   DOI
86 Zahler, S., Tietze, S., Totzke, F., Kubbutat, M., Meijer, L., Vollmar, A. M. and Apostolakis, J. (2007) Inverse in silico screening for identification of kinase inhibitor targets. Chem. Biol. 14, 1207-1214.   DOI
87 Yang, C. H., Kao, M. C., Shih, P. C., Li, K. Y., Tsai, P. S. and Huang, C. J. (2015) Simvastatin attenuates sepsis-induced blood-brain barrier integrity loss. J. Surg. Res. 194, 591-598.   DOI
88 Yang, J. H., Lee, E., Lee, B., Cho, W. K., Ma, J. Y. and Park, K. I. (2018) Ethanolic extracts of Artemisia apiacea Hance improved atopic dermatitis-like skin lesions in vivo and suppressed TNFalpha/IFN-gamma-induced proinflammatory chemokine production in vitro. Nutrients 10, 806.   DOI
89 Yildirim, M. A., Goh, K. I., Cusick, M. E., Barabasi, A. L. and Vidal, M. (2007) Drug-target network. Nat. Biotechnol. 25, 1119-1126.   DOI
90 Hall, C. J., Wicker, S. M., Chien, A. T., Tromp, A., Lawrence, L. M., Sun, X., Krissansen, G. W., Crosier, K. E. and Crosier, P. S. (2014) Repositioning drugs for inflammatory disease - fishing for new antiinflammatory agents. Dis. Model. Mech. 7, 1069-1081.   DOI
91 Hamid, Q. and Tulic, M. (2009) Immunobiology of asthma. Annu. Rev. Physiol. 71, 489-507.   DOI
92 Hasegawa, A., Hayashi, K., Kishimoto, H., Yang, M., Tofukuji, S., Suzuki, K., Nakajima, H., Hoffman, R. M., Shirai, M. and Nakayama, T. (2010) Color-coded real-time cellular imaging of lung T-lymphocyte accumulation and focus formation in a mouse asthma model. J. Allergy Clin. Immunol. 125, 461-468.   DOI
93 Haupt, V. J. and Schroeder, M. (2011) Old friends in new guise: repositioning of known drugs with structural bioinformatics. Brief. Bioinformatics 12, 312-326.   DOI
94 He, L., Peng, X., Zhu, J., Chen, X., Liu, H., Tang, C., Dong, Z., Liu, F. and Peng, Y. (2014) Mangiferin attenuate sepsis-induced acute kidney injury via antioxidant and anti-inflammatory effects. Am. J. Nephrol. 40, 441-450.   DOI
95 Holgate, S. T. (2008) Pathogenesis of asthma. Clin. Exp. Allergy 38, 872-897.   DOI